Table 2.
Baseline clinical, laboratory, and ART information for children living with HIV/AIDS treated at Adama Referral Hospital and Medical College
| Variables | n (%) |
|---|---|
| Functional status (age ≥5 yr) (n=270) | |
| Working | 123 (45.6) |
| Ambulatory | 134 (49.6) |
| Bedridden | 13 (4.8) |
| Developmental history (age <5 yr) (n=158) | |
| Appropriate | 65 (41.1) |
| Delayed | 84 (53.2) |
| Regressive | 9 (5.7) |
| WHO clinical stage | |
| I or II | 237 (55.4) |
| III or IV | 191 (44.6) |
| CD4 count or percent | |
| Below the threshold | 124 (29.0) |
| Above the threshold | 304 (71.0) |
| Hemoglobin level (g/dL) | |
| <10 | 298 (69.6) |
| ≥10 | 130 (30.4) |
| ART eligibility criteria | |
| CD4 cell count | 121 (28.3) |
| WHO clinical stage | 50 (11.7) |
| Both | 171 (39.9) |
| Not recorded | 86 (20.1) |
| Cotrimoxazole preventive therapy (n=362) | |
| Yes | 339 (93.6) |
| No | 23 (6.3) |
| Isoniazid preventive therapy (n=362) | |
| Yes | 154 (42.5) |
| No | 208 (57.5) |
| Types of TB (n=67) | |
| Pulmonary TB | 55 (82.1) |
| Extrapulmonary TB | 12 (17.9) |
| Time TB developed (n=67) | |
| Pre-ART | 48 (71.6) |
| ART | 19 (28.4) |
ART, antiretroviral therapy; WHO, World Health Organization; TB, tuberculosis.